InsidersTradesSigma
康泰医学 Stock: price and directors' dealings · China · SSE / SZSE (CSRC)
Follow the 康泰医学 stock price and the full management transaction log of the company, a publicly traded company based in China. Shares are quoted on CN CN, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 康泰医学 has published 29 public disclosures. Market capitalisation: €6bn. The latest transaction was reported on 14 November 2025 (Sale). Among the most active insiders: 胡坤. Every trade is openly available.
29
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€11m
29 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 19,817 of 26,212 companies
34.1
score / 100
Value32
Quality36
FCF yld-0.6%
Earn yld-0.6%
EV/EBITDA·
ROE-2.7%
Gross mgn48%
Net mgn-5.2%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 14 November 2025
Declarations29 total
25 of 29 declarations
About 康泰医学
康泰医学 is a company specializing in the medical sector, providing innovative solutions for diagnosis and treatment. It is listed on the XSHE market.